Published in Healthcare Mergers, Acquisitions and Ventures Week, April 16th, 2005
The institute will develop research protocols and programs focused on epidemiology, drug safety and quality, pharmaceutical cost containment, medication insurance coverage, use of pharmaceuticals in vulnerable populations and trends in drug management. The institute's initial project will examine the potential association between the use of antipsychotic medications and the risk of developing diabetes.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.